DCF — NEWMAN REGIONAL HEALTH
Enterprise Value: $-174.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-174.5M
Enterprise Value
$-54.1M
PV of Cash Flows
$-120.4M
PV of Terminal Value
$-193.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $76.2M | $-11.5M | -15.0% | $-14.7M | $-13.4M |
| Year 2 | $78.4M | $-11.0M | -14.0% | $-14.4M | $-11.9M |
| Year 3 | $80.8M | $-10.6M | -13.0% | $-14.0M | $-10.5M |
| Year 4 | $83.2M | $-10.5M | -13.0% | $-14.0M | $-9.6M |
| Year 5 | $85.7M | $-10.6M | -12.0% | $-14.2M | $-8.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-174.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$73.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1557151528296242
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5